Home -> Law Blog Directory -> Personal Injury Law Blogs -> Drug and Device Law
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Drug and Device LawA Note on Ackermann v. Wyeth, Learned Intermediaries, and the Heeding Presumption
By James M. Beck and Mark Herrmann
On that issue, Ackermann hits the trifecta for the defense. Ackermann holds, first, that "the read-and-heed presumption does not apply to Texas cases involving learned intermediaries." That's strong precedent for cases pending in the Lone Star State, and one could plainly suggest that other states should follow Texas's lead.
Ackermann holds, second, that, even if a read-and-heed presumption did apply, in the context of learned intermediaries, that presumption would mean "'only that the physician would have incorporated the additional risk into his decisional calculus,'" not that the physician would automatically have decided not to prescribe the drug.
And Ackermann holds, third, that, "even if the [heeding] presumption applied, it would not change the result" in Ackermann itself, given the testimony of the treating physician.
That makes the Fifth Circuit decision in Ackermann an exceptionally strong precedent when plaintiffs assert that a court should presume that a physician would not have prescribed a drug if the package insert had contained some altered warning.
(Oh, yes: If you've ever arguing about whether a drug company should have included a "black box warning" in its package insert, Ackermann's footnote 13 is helpful on that score, correctly suggesting that manufacturers cannot unilaterally add black box warnings, but rather can give those warnings only when the FDA requires them.)
Full post as published by Drug and Device Law on September 30, 2008 (boomark / email).
Wyeth
to Pay Amputee $6.7 Million in Landmark Case
Wyeth Sued Over Rapamune Transplant Drug
Illegal Marketing of Rapamune Sparks Lawsuit

Could New Wyeth Layoffs Spell Trouble for Wyeth 401k Members
Josef Ackermann - Der Victory-Manager
The Necessity of Knowing and Heeding What Jurors Tell Us About Mitigation
Wyeth Investors Lose Out to the Pristiq Fumble
Job Opening: Chief Antitrust Counsel At Wyeth







